Literature DB >> 23940113

The role of SIOP as a platform for communication in the global response to childhood cancer.

Gabriele Calaminus1, Jillian R Birch, Rachel Hollis, Benson Pau, Mariana Kruger.   

Abstract

Since the year 2000, there has been a 35% annual decrease in mortality among children under the age of five worldwide. The decrease is mainly attributed to the decrease in childhood epidemic infections, for example, due to vaccination programs. In the near future, this decrease will draw attention to paediatric non-communicable diseases (NCDs), and cancer is one of the most common. Access to care for children with cancer and survival rates have improved dramatically in high-income countries. However, it is important that a global perspective addresses problems in developing countries in particular. To meet this challenge, it is critical that emphasis is placed on demands such as access to care and drugs that are known to be effective, and which can be safely administered in resource-limited settings. Additionally, cancer registries and improved health care structures that include care for children with cancer, are paramount for further progress to increase awareness and the survival of children with cancer. The purpose of this paper is to describe current worldwide interventions to improve childhood cancer from the perspective of the International Society of Paediatric Oncology (SIOP). This global perspective will serve as an introduction to a series of papers from six SIOP continental branches, which will highlight the specific and/or common issues related to children with cancer worldwide. To strengthen the communication among and synergistic effects of various paediatric cancer stakeholders, SIOP could serve as a global platform for a proposed Global Paediatric Cancer Network through the interaction of its continental branches and partner collaborations.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  adapted protocols; clinical trials; communication platform; developing countries; epidemiology; essential medicines; paediatric haematology/oncology

Mesh:

Year:  2013        PMID: 23940113     DOI: 10.1002/pbc.24728

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

Review 1.  Drug discovery in paediatric oncology: roadblocks to progress.

Authors:  Peter C Adamson; Peter J Houghton; Giorgio Perilongo; Kathy Pritchard-Jones
Journal:  Nat Rev Clin Oncol       Date:  2014-09-16       Impact factor: 66.675

2.  Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program.

Authors:  Roberto Rivera-Luna; Jaime Shalkow-Klincovstein; Liliana Velasco-Hidalgo; Rocio Cárdenas-Cardós; Marta Zapata-Tarrés; Alberto Olaya-Vargas; Marco R Aguilar-Ortiz; Eduardo Altamirano-Alvarez; Cecilia Correa-Gonzalez; Fernando Sánchez-Zubieta; Francisco Pantoja-Guillen
Journal:  BMC Cancer       Date:  2014-10-29       Impact factor: 4.430

3.  Developing a tool for nurses to assess risk of infection in pediatric oncology patients in China: a modified Delphi study.

Authors:  Yufeng Zhou; Yan Cui; Hong Wang; Fang Wang; Chao Lu; Yan Shen
Journal:  J Biomed Res       Date:  2016-06-18

4.  Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda.

Authors:  Gilles Vassal; Edel Fitzgerald; Martin Schrappe; Frédéric Arnold; Jerzy Kowalczyk; David Walker; Lars Hjorth; Riccardo Riccardi; Anita Kienesberger; Kathy-Pritchard Jones; Maria Grazia Valsecchi; Dragana Janic; Henrik Hasle; Pamela Kearns; Giulia Petrarulo; Francesco Florindi; Samira Essiaf; Ruth Ladenstein
Journal:  Pediatr Blood Cancer       Date:  2014-04-07       Impact factor: 3.167

5.  Modified international e-Delphi survey to define healthcare professional competencies for working with teenagers and young adults with cancer.

Authors:  Rachel M Taylor; Richard G Feltbower; Natasha Aslam; Rosalind Raine; Jeremy S Whelan; Faith Gibson
Journal:  BMJ Open       Date:  2016-05-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.